ACTIVE

DOKTER LODE VERMEERSCH, ALGEMENE GENEESKUNDE

Export PDF

Financial year 2024 · Closed on 31/12/2024

Net result86,7 k €+333,5 %over 1 year
Gross margin176,6 k €+97,2 %over 1 year
Equity417,1 k €-3,4 %over 1 year

Identity

Source · BCE/KBO

DOKTER LODE VERMEERSCH, ALGEMENE GENEESKUNDE is a Private limited company incorporated in 2006. Its main activity is: Pre-primary education. Its registered office is in Tremelo.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0879.471.779
Incorporation
08/02/2006
Legal form
Private limited company
Registered office
Baalsebaan 41
3120 Tremelo · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2024
Joint committees (3)
  • 200
  • 305
  • 330
Contacts
2 public details availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 19 filings

Trend over 19 financial years

20242023202220212020
Income statement
Gross margin176,6 k €89,6 k €137,3 k €189,7 k €58,8 k €
EBITDA147,5 k €58,1 k €114,7 k €162,5 k €37,6 k €
Operating result119,7 k €28,5 k €84,8 k €139,1 k €16,8 k €
Net result86,7 k €20 k €62,2 k €99 k €11,5 k €
Balance sheet
Equity417,1 k €431,9 k €411,9 k €363,5 k €299,3 k €
Total assets520,5 k €500,5 k €529,7 k €481 k €307,2 k €
Cash29,1 k €6,3 k €138,5 k €120,1 k €33 k €
Debts100,7 k €66,2 k €115 k €115 k €5,4 k €
Other
Workforce–––––

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

1 active · 2 ended

Active mandates

Lode Vermeersch

Director · since 20 février 2006

Active

Ended mandates

Lode VERMEERSCH

Director

Ended
Lode VERMEERSCH

Manager

Ended

Full financial information

Source · NBB
202420232022202120202019
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date30/09/202531/10/202426/10/202330/09/202203/11/202130/11/2020
General meeting30/09/202530/09/202429/09/202330/09/202228/10/202116/11/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 19 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202430/09/202530/09/2025DutchPDF
Micro model31/12/202330/09/202431/10/2024DutchPDF
Micro model31/12/202229/09/202326/10/2023DutchPDF
Micro model31/12/202130/09/202230/09/2022DutchPDF
Micro model31/12/202028/10/202103/11/2021DutchPDF
Micro model31/12/201916/11/202030/11/2020DutchPDF
Micro model31/12/201813/06/201931/08/2019DutchPDF
Micro model31/12/201714/06/201830/08/2018DutchPDF
Micro model31/12/201608/06/201728/09/2017DutchPDF
Abridged model31/12/201509/06/201631/08/2016DutchPDF
Abridged model31/12/201411/06/201531/08/2015DutchPDF
Abridged model31/12/201312/06/201429/08/2014DutchPDF
Abridged model31/12/201213/06/201330/08/2013DutchPDF
Abridged model31/12/201114/06/201230/08/2012DutchPDF
Abridged model31/12/201009/06/201105/09/2011DutchPDF
Abridged model31/12/200910/06/201031/08/2010DutchPDF
Abridged model31/12/200811/06/200930/09/2009DutchPDF
Abridged model31/12/200712/06/200824/07/2008DutchPDF
Abridged model31/12/200614/06/200713/07/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

1 active · 2 ended

Active mandates

Lode Vermeersch

Director · since 20 février 2006

Active

Ended mandates

Lode VERMEERSCH

Director

Ended
Lode VERMEERSCH

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates05/01/2024
    WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates30/05/2017
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates30/11/2006
    DIVERSEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Other02/03/2006
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 202486,7 k €↑
  2. 2023
    Annual accounts 202320 k €↓
  3. 2022
    Annual accounts 202262,2 k €↓
  4. 2022
    Name changeDokter Lode Vermeersch
  5. 2021
    Annual accounts 202199 k €↑
  6. 2021
    Name changeDokter Lode Vermeersch, Algemene Geneeskunde
  7. 2020
    Annual accounts 202011,5 k €↓
  8. 2019
    Annual accounts 201928,2 k €↓
  9. 2018
    Annual accounts 201834,6 k €↓
  10. 2017
    Annual accounts 201754,4 k €↑
  11. 2016
    Annual accounts 201643,1 k €↑
  12. 2015
    Annual accounts 201532,3 k €↓
  13. 2014
    Annual accounts 201434,7 k €↑
  14. 2013
    Annual accounts 201321,1 k €↑
  15. 2012
    Annual accounts 201218,8 k €↓
  16. 2011
    Annual accounts 201122,8 k €↑
  17. 2010
    Annual accounts 20105,5 k €↓
  18. 2009
    Annual accounts 200915,3 k €↑
  19. 2008
    Annual accounts 20082,3 k €↓
  20. 2007
    Annual accounts 200719,8 k €↑
  21. 2006
    Annual accounts 20068,5 k €
  22. 08/02/2006
    IncorporationPrivate limited company